Cargando…
Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy
Urachal adenocarcinoma (UA) represents a rare subset of bladder tumors involving a urachal remnant. Incidental gross hematuria is often the only presenting symptom, with patients often presenting late in their course, thereby imparting an overall poor prognosis. Although there are prior case reports...
Autores principales: | Patel, Jay, Villegas, Augusto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510567/ https://www.ncbi.nlm.nih.gov/pubmed/37736429 http://dx.doi.org/10.7759/cureus.43849 |
Ejemplares similares
-
Small Bowel Obstruction Due to Metastatic Urachal Adenocarcinoma: A Rare Presentation
por: Sharma, Pranjali, et al.
Publicado: (2021) -
A Rare Case of Incidental Urachal Mucinous Cystadenocarcinoma
por: Komro, Jack, et al.
Publicado: (2020) -
A Case of Acute Encephalopathy After the Initiation of FOLFOX Chemotherapy in a Patient With Colon Cancer
por: Kim, Jin S, et al.
Publicado: (2023) -
A Rare Cause of Urachal Adenocarcinoma: Urachal Diverticle
por: Çiçek, Tufan, et al.
Publicado: (2013) -
Primary Adenocarcinoma of the Jejunum: Case Report of Rare Small Bowel Neoplasm
por: Alherz, Fadhel, et al.
Publicado: (2022)